Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from PopTradeOff: A database for exploring population-specificity of adaptive evolution, disease susceptibility, and drug responsiveness. Local targets link to admitted publications; unresolved targets remain external evidence.
GWAS Central: a comprehensive resource for the discovery and comparison of genotype and phenotype data from genome-wide association studies
2020 · External reference
10.1093/nar/gky1120
10.1093/nar/gky1120 · External reference
An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine
10.1002/cpt.2350 · 2021 · External reference
10.1093/nar/gkj067
10.1093/nar/gkj067 · External reference
Genetic ancestry plays a central role in population pharmacogenomics
10.1038/s42003-021-01681-6 · 2021 · External reference
A global reference for human genetic variation
10.1038/nature15393 · 2015 · External reference
10.1126/science.aaf5098
10.1126/science.aaf5098 · External reference
10.1016/j.gde.2014.06.011
10.1016/j.gde.2014.06.011 · External reference
10.1038/s41576-020-00305-9
10.1038/s41576-020-00305-9 · External reference
10.1016/j.cell.2019.01.052
10.1016/j.cell.2019.01.052 · External reference
10.1016/j.celrep.2022.111351
10.1016/j.celrep.2022.111351 · External reference
10.1111/j.1529-8817.2005.00180.x
10.1111/j.1529-8817.2005.00180.x · External reference
Stroke Collaborators (2021). Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
2019 · External reference
10.1146/annurev-genet-111212-133526
10.1146/annurev-genet-111212-133526 · External reference
10.1016/j.cell.2013.01.035
10.1016/j.cell.2013.01.035 · External reference
10.1126/science.1124309
10.1126/science.1124309 · External reference
10.1093/nar/gkab1049
10.1093/nar/gkab1049 · External reference
10.1101/gr.3709305
10.1101/gr.3709305 · External reference
Localization of adaptive variants in human genomes using averaged one-dependence estimation
10.1038/s41467-018-03100-7 · 2018 · External reference
Pharmacogenomics knowledge for personalized medicine
10.1038/clpt.2012.96 · 2012 · External reference
10.1093/nar/28.1.27
10.1093/nar/28.1.27 · External reference
10.1038/75556
10.1038/75556 · External reference
10.1093/nar/gkaa1113
10.1093/nar/gkaa1113 · External reference
10.1093/nar/gkz888
10.1093/nar/gkz888 · External reference
10.1038/s41586-020-03145-z
10.1038/s41586-020-03145-z · External reference
10.1038/nature11247
10.1038/nature11247 · External reference
igv.js: an embeddable JavaScript implementation of the Integrative Genomics Viewer (IGV)
2023 · External reference
Comparison of pharmacokinetics and pharmacogenetics of once- and twice-daily tacrolimus in the early stage after renal transplantation
10.1097/tp.0b013e31826bc400 · 2012 · External reference
CYP3A5 *1 allele associated with tacrolimus trough concentrations but not subclinical acute rejection or chronic allograft nephropathy in Japanese renal transplant recipients
10.1007/s00228-008-0606-3 · 2009 · External reference
Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation
10.1016/j.clinthera.2013.08.019 · 2013 · External reference
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjects
10.1016/j.clpt.2006.09.009 · 2006 · External reference
Lipid-lowering response to statins is affected by CYP3A5 polymorphism
10.1097/01.fpc.0000114762.78957.a5 · 2004 · External reference
Impact of pharmacogenetics on statin-induced myopathy in South-Indian subjects
10.1016/j.ihj.2018.07.009 · 2018 · External reference
An association study of 43 SNPs in 16 candidate genes with atorvastatin response
2005 · External reference
The effect of CYP3A5 polymorphism on dose-adjusted cyclosporine concentration in renal transplant recipients: a meta-analysis
2011 · External reference
Calcium-channel blockers: clinical outcome associations with reported pharmacogenetics variants in 32 000 patients
2022 · External reference
10.1093/nar/gkt1052
10.1093/nar/gkt1052 · External reference
10.1093/nar/gkt1188
10.1093/nar/gkt1188 · External reference
10.1093/nar/gky959
10.1093/nar/gky959 · External reference